SGHT vs XLI
Sight Sciences Inc (SGHT) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Sight Sciences Inc (SGHT) is a medical devices company listed on NASDAQ.
XLI (XLI) common stock.
Latest reported SGHT revenue for 2026-06-30 was $43.1M. Net income was -$17.4M. SGHT currently screens at market cap $273.1M.
XLI does not have a complete income-statement cache yet.
SGHT currently screens at market cap $273.1M. XLI currently screens at market cap $0.
Not investment advice. Open the SGHT and XLI stock pages for the full models.
Not investment advice.